Comparative haemodynamic effects of intravenous flecainide in patients with and without heart failure and with and without beta-blocker therapy
Authors:
- 1 August 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 6 (8) , 664-671
Abstract
The haemodynamic effects of flecainide were compared in three different subsets of patients with documented coronary disease. Ten patients (A) had no heart failure, 5 patients were on beta blockers (B) and 5 patients had overt heart failure (C). Flecainide was associated with negative inotropic effects that were relatively more pronounced in patients with left ventricular dysfunction: pulmonary wedge pressure increased by 27% in A, by 31% in B and by 42% in C; left ventricular stroke volume and stroke work decreased respectively by 10 and 12% in A, 21 and 19% in B, 26 and 28% in C. Ejection fraction decreased by 9% in A, 13% in B and 20% in C, in relation with an increase in end systolic volume ( + 9% in A, +10% in Band + 5%inC). Absolute changes, however, were not significantly different from one group to another except for the increase of systemic vascular resistance which was more pronounced in C as compared with the other groups. The myocardial depression was also confirmed by the fall in dPjdt that was maximal at the end of injection; dP/dt remained depressed 15 min later despite some improvement. Flecainide thus exerts negative inotropic effects that are maximal at the end of infusion and may be of importance in patients with established left ventricular dysfunction.Keywords
This publication has 10 references indexed in Scilit:
- Emergency transvenous ablation of atrioventricular conduction to control refractory atrial tachycardiaEuropean Heart Journal, 1984
- Proarrhythmic effects of the new antiarrhythmic agent flecainide acetateAmerican Heart Journal, 1984
- The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease.British Journal of Clinical Pharmacology, 1983
- Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardiaJACC, 1983
- Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.Circulation, 1983
- Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardiasThe American Journal of Cardiology, 1983
- Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart diseaseThe American Journal of Cardiology, 1983
- Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.Circulation, 1982
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981
- Effects of contrast medium on left ventricular pressure and volume with emphasis on coronary artery diseaseAmerican Heart Journal, 1977